Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Dare Bioscience (DARE) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

DARE

Get DARE alerts
Open-market purchases0 insidersno buys · last 12 months
Insiders selling1last 12 months
Reported sales$3820 of 1 recent sales pre-planned (10b5-1)
In 15 seconds

No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification) and isn't treated as a signal here.

Label: Net selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
Latest open-market trade

Sale William H. Rastetter, Director sold 859 shares at $0.45 ($382).

Trade date
Nov 19, 2026
Disclosed to the SEC
Nov 20, 2026
Type
Sale (code S)

Read the original SEC filing ↗All DARE insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

DARE insider transactions (Form 4)

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Nov 20 NewSEC William H. RastetterDirector Sell 859 $0.45 $382 — —
Historical context

Similar past setups: not applicable. DARE has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with DARE in the Research Lab

DARE has no open-market insider buys in the last 12 months. Try the tools with any setup.

All tools →

Quick backtest: did buys like this beat the market?

Insiders buying
CEO or CFO
Dollar size
Stock before

Tap a setting to see how 6,290 past insider buys did.

Open the full Backtester →

Share price and insider trades

DARE closeInsider buyInsider sale

Price history unavailable.

Bought, 12 months$0
Sold, 12 months$382
Insiders buying0
Insiders selling1

Dare Bioscience insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 1 sold $382 of DARE stock on the open market.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings · How we calculate this

DARE insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2026: $382 sold (1 trades)Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0$3821

Valuation, profit and volume

Valuation figures for DARE are refreshed each weekday; some aren't published for every company. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 0 Dare Bioscience, Inc. insiders reported open-market purchases totaling $0, while 1 insider reported sales totaling $382. 0 of 1 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insiders at Dare Bioscience, Inc.

InsiderBoughtSoldLast filingPast buys beat S&PScore
William H. RastetterDirector — $382 Nov 20, 2026 — —

Board links: companies that share insiders with DARE

Directors and executives who filed Form 4s for DARE and another company in the last 12 months.

See the map →

DARE stock: common questions

Are Dare Bioscience, Inc. insiders buying DARE stock?

No. No Dare Bioscience, Inc. insider reported an open-market purchase of DARE in the past 12 months.

Are Dare Bioscience, Inc. insiders selling DARE stock?

1 insider reported sales worth $382 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.